Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smiths Medical, formerly known as Smith Industries Medical Systems (SIMS), was a leading global manufacturer of specialty medical devices and equipment for hospital, emergency, home, and specialist environments. The company's extensive portfolio focused on infusion therapy, vascular access, and vital care, featuring market-leading brands such as Portex, Medex, Deltec, and Level 1. Its products were essential in clinical areas including anesthesia, oncology, intensive care, and pain management. In January 2022, Smiths Medical was acquired by ICU Medical for approximately $2.8 billion in a cash and stock transaction, creating a combined leader in infusion therapy. The integration aimed to leverage Smiths Medical's global reach and diverse product lines to enhance ICU Medical's position in the healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smith Industries Medical Systems.